Clinical Trial Site Intelligence
Sandra Shpilberg
Co-Founder & CEO @ Adnexi - To accelerate treatment development, Adnexi finds, profiles and engages the most influential health experts - using a lot of technology!
Finding the right clinical trial sites can make or break a clinical trial. If your team select sites that are inexperienced it may delay the clinical trial enrollment and the eventual approval of the new treatment or medical device.
Situation:
A biopharmaceutical company partnering with Adnexi faced a critical challenge in selecting optimal Phase 2 clinical trial sites for their new treatment. The success of the clinical trial hinged on choosing sites with experienced investigators who could effectively enroll participants according to strict inclusion and exclusion criteria. Previous trials had encountered delays due to ineffective site selection, prompting the company to seek a more data-driven approach to streamline the process and accelerate trial initiation.
Methods:
Adnexi leveraged advanced data processing techniques to analyze vast amounts of unstructured data that were previously inaccessible. They focused on extracting and evaluating inclusion and exclusion criteria from past studies. This data was transformed into actionable insights, enabling the team to create a ranking system for potential clinical trial sites. By utilizing cutting-edge technology, Adnexi aimed to mitigate the risks associated with inexperienced sites and expedite the startup of the Phase 2 clinical trial.
Results:
Through Adnexi’s innovative approach, the biopharmaceutical company successfully identified and prioritized optimal clinical trial sites for their Phase 2 study. The actionable insights derived from historical data allowed the team to confidently select sites with a track record of meeting enrollment targets and adhering to stringent protocol requirements. This strategic site selection not only minimized the risk of enrollment delays but also positioned the company favorably for subsequent regulatory approvals.
Ultimately, Adnexi’s data-driven methodology significantly enhanced the efficiency and success rate of the clinical trial startup process, illustrating the transformative impact of leveraging advanced technology in site selection within the pharmaceutical industry.
Next Steps:
If you have similar challenges finding the right clinical trial sites, we can help - using the latest technology. Please contact:
Meagan Mansfield
Co-Founder & CEO @ Adnexi - To accelerate treatment development, Adnexi finds, profiles and engages the most influential health experts - using a lot of technology!
7 个月Meagan Mansfield